Cialis, the trademark drug of Lilly Icos can be beneficial to human beings in ways other than curing erectile dysfunction. Clinical researches have found out that tadalafil, the main component of Cialis can help people in reducing their blood pressure, keep a widespread prostrate condition under control and deal with an impending lung disorder. These additional benefits of Cialis have made the future of Lilly Icos brighter.

David Goodkin, the Senior Vice President at Icos stated in a press release that the company is constantly working towards development of the drug for any other potential benefits. Even tadalafil, the active ingredient in Cialis, was earlier developed as angina drug years before its impotency curing properties were realized.

Icos announced that it would utilize the mechanism of Cialis for the effective treatment of hypertension or chronic high blood pressure. Goodkin said there are around 50 million people with hypertension in the United States alone. Though many drugs to cure chronic high blood pressure are available, none of them are free of major side effects. Cialis may prove to be the dream drug, with negligible side effects.

Lilly Icos went ahead with a phase 2 study of Cialis to investigate the effects of tadalafil on persons with hypertension. The result of the study was clinically meaningful. It established that tadalafil showed compatible effects to the other drugs in the market. The only difference came up in the form of side effects. All the other drugs impeded sex, whereas Cialis gave an altogether opposite effect.

Tadalafil can also treat the symptoms of Benign Prostatic Hyperplasia, a common prostate problem. A patient with this problem administered with a dose of tadalafil showed a statistically remarkable improvement. A thorough medical assessment of the patient demonstrated that Cialis can be an effective drug for men with benign prostatic hyperplasia.

Pulmonary arterial hypertension is a rare problem of the lungs, which is characterized by an increased pressure in the arteries of the lungs. People diagnosed with this condition rarely survive for more than three years. It normally occurs in people who are under 30 years of age, generally causing fatigue, shortness of breath and heart failure. The drugs to treat pulmonary arterial hypertension have an adverse effect on the liver. The FDA has already approved sildenafil as a potential drug for this condition without the risk of the harmful side effects. This has heightened the possibilities of tadalafil as a treatment.

Goodkin and other medical scientists in Icos said that many of the erectile dysfunction patients have other health problems that can be cured by Cialis. Biotechnologists are of the opinion that Cialis is one of those few wonder drugs that have multi-beneficial properties. This is certainly good news for Lilly Icos.